Marathon Trading Investment Management’s Zoom ZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$209K Buy
+2,600
New +$218K 0.01% 178
2025
Q3
Sell
-1,600
Closed -$125K 361
2025
Q2
$125K Buy
+1,600
New +$124K 0.01% 208
2025
Q1
Sell
-2,700
Closed -$220K 426
2024
Q4
$220K Buy
+2,700
New +$212K 0.01% 205
2024
Q3
Sell
-5,000
Closed -$296K 351
2024
Q2
$296K Sell
5,000
-5,700
-53% -$350K 0.02% 164
2024
Q1
$699K Buy
10,700
+2,800
+35% +$187K 0.05% 133
2023
Q4
$568K Buy
7,900
+7,100
+888% +$470K 0.03% 201
2023
Q3
$56K Sell
800
-400
-33% -$27.8K ﹤0.01% 267
2023
Q2
$81.5K Sell
1,200
-4,000
-77% -$267K 0.01% 214
2023
Q1
$384K Buy
+5,200
New +$375K 0.03% 143
2022
Q3
Sell
-2,700
Closed -$292K 327
2022
Q2
$292K Sell
2,700
-500
-16% -$52.7K 0.03% 196
2022
Q1
$375K Buy
+3,200
New +$435K 0.03% 195
2021
Q4
Sell
-5,800
Closed -$1.52M 429
2021
Q3
$1.52M Buy
+5,800
New +$1.96M 0.11% 117
2021
Q2
Sell
-1,100
Closed -$353K 424
2021
Q1
$353K Buy
+1,100
New +$405K 0.03% 244

Other funds holding ZM

Marathon Trading Investment Management's ZM Position: Q3 2025 in Review

Marathon Trading Investment Management sold out of Zoom (ZM) in Q3 2025, closing a stake of 1,548 shares — an estimated $121K sold.

Marathon Trading Investment Management first reported a position in ZM in Q3 2021 and held it in 7 quarters. The position peaked at $626K in Q3 2023. 753 funds tracked by Wall St. Rank hold ZM as of Q3 2025.

  • Marathon Trading Investment Management reported no remaining Zoom position as of Q3 2025 after selling out during the quarter.
  • Marathon Trading Investment Management sold 1,548 Zoom shares in Q3 2025, an estimated $121K.
  • Marathon Trading Investment Management first reported a position in Zoom in Q3 2021 and held it in 7 quarters.
  • Marathon Trading Investment Management's Zoom position peaked at $626K in Q3 2023.
  • 753 funds tracked by Wall St. Rank held Zoom as of Q3 2025.

Based on Marathon Trading Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.